Navigation Links
Moffitt Cancer Center instrumental in new clinical guidelines for cancer-related fatigue
Date:5/30/2014

TAMPA, Fla. (May 30, 2014) Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life. Approximately 30 percent of cancer patients endure persistent fatigue for several years after treatment, according to an American Society of Clinical Oncology Expert Panel co-chaired by Paul Jacobsen, Ph.D., associate center director of Population Sciences at Moffitt Cancer Center.

ASCO created the panel to develop assessment, screening, and treatment guidelines for medical professionals to help patients who experience fatigue after completing primary treatment. The panel analyzed several national guidelines from the United States and Canada, and reviewed published studies about cancer-related fatigue to create the new guidelines.

The panel recommends that all health care professions regularly screen and measure fatigue and other associated problems in cancer patients through health history, physical examinations, and laboratory analysis. It is important for all patients to be educated about fatigue and its associated medical problems.

Fatigue in cancer patients after treatment can arise from other problems, such as depression, pain, anxiety, nutritional deficits, medications, or emotional distress. The panel recommends that all contributing factors should be identified and treated before the symptoms of fatigue are addressed.

There are a number of treatment and care options for patients experiencing continued fatigue. "Studies show that initiating or maintaining adequate levels of physical activity can reduce cancer-related fatigue in post-treatment patients. Physicians should actively encourage all patients to engage in a moderate level of physical activity after cancer treatment, dependent on risk of injury," said Jacobsen.

Behavioral and psychoeducational therapies have also been reported to reduce fatigue in cancer patients. The panel recommends that patients interested in these options be referred to psychosocial service providers who specialize in cancer. Some studies also suggest that yoga, acupuncture and mindfulness-based approaches may also be beneficial.

The panel does not recommend medication to alleviate fatigue in cancer patients after treatment. While some data suggest that medication can help patients suffering from fatigue who have advanced disease or are receiving cancer treatment, there is insufficient evidence that these medications relieve fatigue in patients after treatment.

The new guidelines appeared in the April 14 issue of the Journal of Clinical Oncology.


'/>"/>

Contact: Kim Polacek
Kim.Polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Moffitt Cancer Centers phase 3 study may be game-changer for acute myeloid leukemia
2. Moffitt Cancer Center begins Phase I clinical trial of new immunotherapy
3. Moffitt instrumental in FDA approval of revolutionary 2-drug combo to treat advanced melanoma
4. Moffitt Cancer Center launches prostate cancer study focused on black men
5. Single injection may revolutionize melanoma treatment, Moffitt study shows
6. Moffitt researchers identify gene variations that may help predict cancer treatment response
7. Moffitt Cancer Center expert standardizing guidelines for penile cancer treatment
8. Protein complex linked to cancer growth may also help fight tumors, Moffitt researchers say
9. Single men, smokers at higher risk for oral human papillomavirus infection, Moffitt study shows
10. How to boost Hispanics participation in clinical trials? Relate to them, Moffitt study shows
11. New screening approach identifies small proteins unique to melanoma cells, Moffitt researcher says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: